Glenn A. Eisenberg - Apr 30, 2024 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Role: Chief Financial Officer, EVP
Signature: /s/ Sandra D. van der Vaart, Attorney-in-Fact for Glenn A. Eisenberg
Stock symbol: LH
Transactions as of: Apr 30, 2024
Transactions value $: -$905,360
Form type: 4
Date filed: 5/2/2024, 12:45 PM
Previous filing: Apr 17, 2024
Next filing: May 15, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LH	Common Stock	Options Exercise		+10.2K	+25.22%		50.8K	Apr 30, 2024	Direct	F1
transaction	LH	Common Stock	Tax liability	-$905K	-4.5K	-8.85%	$201.37	46.3K	Apr 30, 2024	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LH	Performance Share Unit	Options Exercise		-10.2K	-100%		0	Apr 30, 2024	Common Stock	10.2K		Direct	F1, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Performance Share represents the contingent right to receive one share of Laboratory Corporation of America Holdings ("Labcorp") Common Stock.
F2	Stock withholding to satisfy tax withholding obligations.
F3	Amount includes an additional 1,059 Performance Shares resulting from the final adjustment ratio calculated pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea Holdings Inc. ("Fortrea").
F4	The Performance Shares vested in full upon the filing of the Company's Quarterly Report on Form 10-Q for the first quarter of 2024, subject to both continued service and satisfaction of a performance condition related to the spin-off of Fortrea.